{"id":828475,"date":"2025-03-21T08:33:37","date_gmt":"2025-03-21T12:33:37","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/"},"modified":"2025-03-21T08:33:37","modified_gmt":"2025-03-21T12:33:37","slug":"biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/","title":{"rendered":"BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SUNNYVALE, Calif., March  21, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sKkqrLdmXQFJlZvTFzAPdVWb-OjGgycU0rrOU5ng1TmGJJfg67mQ6sGOAm3w1R-XrC9C6ety_eQ65y36WVWxapmeVCTJ5ZdMgzd3gc01fVs=\" rel=\"nofollow\" target=\"_blank\">BioCardia<sup>\u00ae<\/sup>, Inc.<\/a> [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will report its financial results for the year ended December 31, 2024 on Wednesday, March 26, 2025, and will host a corporate update conference call on Monday, March 31, 2025 (time and dial-information to be announced). The conference call will follow the presentation, \u201cA Double-blind, Randomized Controlled Trial of an Autologous Cell Therapy in Patients with HFrEF: Principal Results from the CardiAMP-HF Trial,\u201d at the American College of Cardiology 2025 Scientific Sessions in Chicago on March 30, 2025.<\/p>\n<p>\n        <strong>About BioCardia<sup>\u00ae<\/sup><\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sKkqrLdmXQFJlZvTFzAPdYo4CPlXUTLF2xxEB0O-9ONIahcdYusg_bw8GtnsVRpy5u92obijKMRQd9CZ-e0cWDZyNgNyatrDHFc6hKW3Q7k=\" rel=\"nofollow\" target=\"_blank\">BioCardia, Inc.<\/a>,\u00a0headquartered in Sunnyvale, California, is a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease. CardiAMP<sup>\u00ae<\/sup> autologous and CardiALLO\u2122 allogeneic cell therapies are the Company\u2019s biotherapeutic platforms with three cardiac clinical stage product candidates in development. These therapies are enabled by its Helix\u2122 biotherapeutic delivery and Morph<sup>\u00ae<\/sup> vascular navigation product platforms. For more information visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=j8NbFeJ6u5jQesWdDPC8BloQYGjAalHntkDtf500yzsRf2gb56_tUM_mWT19ZileU-kvdKTH3HitwpgMGBwaYsVcy4RGZw0c9swbl734Pq0=\" rel=\"nofollow\" target=\"_blank\">www.biocardia.com<\/a>.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODQ4NSM2ODE3NTQzIzIwMTk4MTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZGMyNmMwMWMtZjZmMC00ZmM4LTgyMzYtOGUzYTg0MWVjOWNiLTEwMzEzOTEtMjAyNS0wMy0yMS1lbg==\/tiny\/BioCardia-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>MEDIA CONTACT:\r\nMiranda Peto, Investor Relations\r\nmpeto@biocardia.com\r\n(650) 226-0120\r\n\r\nINVESTOR CONTACT:\r\nDavid McClung, Chief Financial Officer\r\ninvestors@biocardia.com\r\n(650) 226-0120<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SUNNYVALE, Calif., March 21, 2025 (GLOBE NEWSWIRE) &#8212; BioCardia\u00ae, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will report its financial results for the year ended December 31, 2024 on Wednesday, March 26, 2025, and will host a corporate update conference call on Monday, March 31, 2025 (time and dial-information to be announced). The conference call will follow the presentation, \u201cA Double-blind, Randomized Controlled Trial of an Autologous Cell Therapy in Patients with HFrEF: Principal Results from the CardiAMP-HF Trial,\u201d at the American College of Cardiology 2025 Scientific Sessions in Chicago on March 30, 2025. About BioCardia\u00ae BioCardia, Inc.,\u00a0headquartered in Sunnyvale, California, is a global leader in cellular &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-828475","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SUNNYVALE, Calif., March 21, 2025 (GLOBE NEWSWIRE) &#8212; BioCardia\u00ae, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will report its financial results for the year ended December 31, 2024 on Wednesday, March 26, 2025, and will host a corporate update conference call on Monday, March 31, 2025 (time and dial-information to be announced). The conference call will follow the presentation, \u201cA Double-blind, Randomized Controlled Trial of an Autologous Cell Therapy in Patients with HFrEF: Principal Results from the CardiAMP-HF Trial,\u201d at the American College of Cardiology 2025 Scientific Sessions in Chicago on March 30, 2025. About BioCardia\u00ae BioCardia, Inc.,\u00a0headquartered in Sunnyvale, California, is a global leader in cellular &hellip; Continue reading &quot;BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-21T12:33:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODQ4NSM2ODE3NTQzIzIwMTk4MTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025\",\"datePublished\":\"2025-03-21T12:33:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\\\/\"},\"wordCount\":178,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5ODQ4NSM2ODE3NTQzIzIwMTk4MTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\\\/\",\"name\":\"BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5ODQ4NSM2ODE3NTQzIzIwMTk4MTk=\",\"datePublished\":\"2025-03-21T12:33:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5ODQ4NSM2ODE3NTQzIzIwMTk4MTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5ODQ4NSM2ODE3NTQzIzIwMTk4MTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/","og_locale":"en_US","og_type":"article","og_title":"BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025 - Market Newsdesk","og_description":"SUNNYVALE, Calif., March 21, 2025 (GLOBE NEWSWIRE) &#8212; BioCardia\u00ae, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will report its financial results for the year ended December 31, 2024 on Wednesday, March 26, 2025, and will host a corporate update conference call on Monday, March 31, 2025 (time and dial-information to be announced). The conference call will follow the presentation, \u201cA Double-blind, Randomized Controlled Trial of an Autologous Cell Therapy in Patients with HFrEF: Principal Results from the CardiAMP-HF Trial,\u201d at the American College of Cardiology 2025 Scientific Sessions in Chicago on March 30, 2025. About BioCardia\u00ae BioCardia, Inc.,\u00a0headquartered in Sunnyvale, California, is a global leader in cellular &hellip; Continue reading \"BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-21T12:33:37+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODQ4NSM2ODE3NTQzIzIwMTk4MTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025","datePublished":"2025-03-21T12:33:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/"},"wordCount":178,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODQ4NSM2ODE3NTQzIzIwMTk4MTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/","name":"BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODQ4NSM2ODE3NTQzIzIwMTk4MTk=","datePublished":"2025-03-21T12:33:37+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODQ4NSM2ODE3NTQzIzIwMTk4MTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5ODQ4NSM2ODE3NTQzIzIwMTk4MTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocardia-to-host-2024-financial-results-and-corporate-update-conference-call-on-march-31-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/828475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=828475"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/828475\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=828475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=828475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=828475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}